PortViewPortView
Tivic Health Systems logo

Tivic Health Systems (TIVC) Stock Analysis

NASDAQHealthcareMedical - Specialties

$0.26-10.46%
1-year price historyRange $0.12 – $3.20
52-week range$0.26
$0.26$5.60

What Tivic Health Systems does

Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.

Key metrics

Market cap
$279,155
P/E (TTM)
-0.04
EPS (TTM)
$-6.92
Beta
1.83
Dividend yield
0.00%
Revenue / share
$-1.15
50-day avg
$0.96
200-day avg
$2.09
52-week high
$5.60
52-week low
$0.26
CEO
Michael Kevin Handley

ETFs linked to TIVC

Broad-market and Healthcare sector ETFs an investor holding Tivic Health Systems is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TIVC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TIVC in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Tivic Health Systems?
Tivic Health Systems trades under the ticker TIVC on NASDAQ.
Which exchange is TIVC listed on?
TIVC is listed on NASDAQ.
What sector does Tivic Health Systems operate in?
Tivic Health Systems is classified in the Healthcare sector (Medical - Specialties industry).
How can PortView help analyze TIVC in a portfolio?
PortView shows TIVC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.